AAAAAA
Results: 1-25/95
Authors:
Kokmen, E
Cha, RH
Rocca, WA
Citation: E. Kokmen et al., Time trends in the prevalence of dementia and Alzheimer's disease in Rochester, Minnesota, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 3-7
Authors:
Launer, LJ
Fratiglioni, L
Andersen, K
Breteler, MMB
Copeland, RJM
Dartigues, JF
Lobo, A
Martinez-Lage, J
Soininen, H
Hofman, A
Citation: Lj. Launer et al., Regional differences in the incidence of dementia in Europe: EURODEM collaborative analyses, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 9-15
Authors:
Kilander, L
Nyman, H
Hansson, L
Boberg, M
Lithell, H
Citation: L. Kilander et al., Cerebrovascular risk factors are determinants of low cognitive function: A20-year follow-up of 999 elderly men, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 17-24
Authors:
Helmer, C
Damon, D
Letenneur, L
Dartigues, JF
Citation: C. Helmer et al., Marital status and risk of Alzheimer's disease: A French population-based cohort study, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 25-31
Authors:
Viitanen, M
Guo, ZC
Fratiglioni, L
Zhu, L
Fastbom, J
Winblad, B
Citation: M. Viitanen et al., The influence of diuretics on the occurrence and progression of dementia in a community population aged 75 years and over, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 33-38
Authors:
Jagger, C
Andersen, K
Breteler, MMB
Copeland, JRM
Dartigues, JF
Di Carlo, A
Fratiglioni, L
Lobo, A
Schmidt, R
Soininen, H
Hofman, A
Launer, LJ
Citation: C. Jagger et al., Prognosis with dementia: Results from a European collaborative analysis ofpopulation-based studies, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 39-44
Authors:
Lambert, JC
Berr, C
Pasquier, F
Delacourte, A
Frigard, B
Cottel, D
Perez-Tur, J
Mouroux, V
Mohr, M
Cecyre, D
Galasko, D
Lendon, C
Poirier, J
Hardy, J
Mann, D
Amouyel, P
Chartier-Harlin, MC
Citation: Jc. Lambert et al., The risk of developing Alzheimer's disease associated with the APOE promoter polymorphisms, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 47-52
Authors:
Amouyel, P
Richard, F
Lambert, JC
Chartier-Harlin, MC
Helbecque, N
Citation: P. Amouyel et al., Apolipoprotein E, vascular factors and Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 53-58
Authors:
Hol, EM
Sluijs, JA
Sonnemans, MAF
Smit, AB
Van der Schors, RC
Van Leeuwen, FW
Citation: Em. Hol et al., Molecular misreading and accumulation of+1 proteins in Alzheimer's and Down's syndrome patients, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 59-67
Authors:
Kwok, JBJ
Li, QX
Hallupp, M
Milward, L
Whyte, S
Schofield, PR
Citation: Jbj. Kwok et al., Novel familial early-onset Alzheimer's disease mutation (Leu723Pro) in amyloid precursor protein (APP) gene increases production of 42(43) amino acidisoform of amyloid-beta peptide, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 69-79
Authors:
De Jonghe, C
Tysoe, C
Cruts, M
Vanderhoeven, I
Vanderstichele, H
Vanmechelen, E
Van Broeckhoven, C
Rubinsztein, DC
Hendriks, L
Citation: C. De Jonghe et al., A presenilin-1 truncating mutation causing Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 81-86
Authors:
Dermaut, B
Cruts, M
Slooter, AJC
Van Gestel, S
De Jonghe, C
Backhovens, H
Vanderstichele, H
Vanmechelen, E
Breteler, MMB
Hofman, A
Hendriks, L
Van Duijn, CM
Van Broeckhoven, C
Citation: B. Dermaut et al., Glu318Gly in presenilin-1 is a neutral mutation in relation to dementia: The Rotterdam study, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 87-92
Authors:
Cacabelos, R
Beyer, K
Lao, JI
Mesa, MD
Fernandez-Novoa, L
Citation: R. Cacabelos et al., Association of genetic risk factors in Alzheimer's disease and a novel mutation in the predicted TM2 domain of the presenilin-2 gene in late-onset AD, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 93-102
Authors:
de Leon, MJ
Convit, A
De Santi, S
Bobinski, H
Citation: Mj. De Leon et al., Structural neuroimaging: Early diagnosis and staging of Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 105-126
Authors:
Orgogozo, JM
Fabrigoule, C
Dartigues, JF
Citation: Jm. Orgogozo et al., Early diagnosis of Alzheimer's disease with simple neuropsychological tests, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 127-135
Authors:
Duyckaerts, C
Colle, MA
Hauw, JJ
Citation: C. Duyckaerts et al., A sketch of Alzheimer's disease histopathology, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 137-151
Authors:
Sparks, DL
Citation: Dl. Sparks, Neuropathologic links between Alzheimer's disease and vascular disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 153-163
Authors:
Farkas, E
De Jong, GI
De Vos, RAI
Steur, ENHJ
Luiten, PGM
Citation: E. Farkas et al., Cerebral microvascular breakdown in Alzheimer's disease and in experimental cerebral hypoperfusion, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 165-170
Authors:
Wisniewski, HM
Sadowski, M
Wegiel, J
Golabek, A
Kida, E
Citation: Hm. Wisniewski et al., Brain region differences in fibrillization of A beta proteins and the roleof microglia in transformation of diffuse into neuritic plaques, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 171-178
Authors:
Schultz, C
Ghebremedhin, E
Sassin, I
Braak, E
Braak, H
Citation: C. Schultz et al., Abnormally phosphorylated tau protein in neurons and glial cells of aged baboons, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 179-185
Authors:
Ruben, GC
Wang, JZ
Grundke-Iqbal, I
Iqbal, K
Citation: Gc. Ruben et al., Paired helical filaments have a wide range of widths with similar helical periods, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 187-192
Authors:
Tapiola, T
Lehtovirta, M
Pirttila, T
Alafuzoff, I
Riekkinen, P
Soininen, H
Citation: T. Tapiola et al., Cerebrospinal fluid aspartate aminotransferase activity is increased in Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 193-197
Authors:
Efthimiopoulos, S
Georgakopoulos, A
Floor, E
Shioi, J
Cui, W
Wisniewski, T
Robakis, NK
Citation: S. Efthimiopoulos et al., Enrichment of presenilin 1 peptides in the membranes of neuronal vesicles:Implications for Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 201-212
Authors:
Grunberg, J
Walter, J
Haass, C
Citation: J. Grunberg et al., The 18-20 kDa C-terminal fragment of presenilin-1 is the major in vivo substrate for proteases of the caspase family, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 213-220
Authors:
Holtzman, DM
LaDu, MJ
Van Eldik, L
Bu, GJ
Wu, S
Patel, S
Fagan, AM
Sun, YL
Citation: Dm. Holtzman et al., Biological effects of astrocyte-secreted apoE/lipoproteins: Role of LRP, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 221-230